Cryoport (NASDAQ:CYRX) Posts Earnings Results, Misses Expectations By $0.09 EPS

Cryoport (NASDAQ:CYRX) issued its earnings results on Tuesday. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by ($0.09), Zacks reports. Cryoport had a negative return on equity of 13.35% and a negative net margin of 70.08%. The firm had revenue of $59.53 million during the quarter, compared to the consensus estimate of $58.71 million. During the same quarter in the prior year, the business posted ($0.29) EPS. Cryoport updated its FY 2025 guidance to EPS.

Cryoport Price Performance

CYRX stock opened at $6.61 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 5.70 and a quick ratio of 5.32. Cryoport has a 1 year low of $4.58 and a 1 year high of $20.10. The firm has a 50-day moving average of $7.34 and a 200 day moving average of $7.62. The company has a market cap of $326.74 million, a P/E ratio of -1.96 and a beta of 1.59.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CYRX. Roth Mkm decreased their price objective on shares of Cryoport from $18.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, November 8th. Needham & Company LLC restated a “buy” rating and set a $11.00 price target on shares of Cryoport in a report on Wednesday. Finally, Guggenheim began coverage on Cryoport in a research report on Thursday, December 19th. They set a “buy” rating and a $11.00 price target for the company. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $12.29.

About Cryoport

Cryoport, Inc provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services.